-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
SSAA09E3
Category | SARS-CoV |
CAS | 52869-18-8 |
Description | SSAA09E3 is a novel inhibitor of SARS-CoV and HIV-1. SSAA09E3 blocks SARS-CoV entry by preventing fusion of the viral membrane with the host cellular membrane. |
Product Information
Synonyms | SSAA09E3;52869-18-8;N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide;N-(9,10-dioxoanthracen-2-yl)benzamide;N-(2-ANTHRAQUINONYL)BENZAMIDE;N1-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide;Anthraquinone, 2-benzamido-;SSAA09E3?;med.21724, Compound 25;SCHEMBL8528763;CHEMBL5280105;DTXSID70341119;SIGATAYQAZTAOH-UHFFFAOYSA-N;BDBM429289;GLXC-03526;EX-A8530;CCG-45824;STK362117;AKOS001652216;DA-58082;MS-24886;HY-138102;CS-0144972;NS00016609;G72176;AB00079640-01;SR-01000635570-1;N-(9,10-Dioxo-9,10-dihydro-2-anthracenyl)benzamide #; |
IUPAC Name | N-(9,10-dioxoanthracen-2-yl)benzamide |
Molecular Weight | 190.7 |
Molecular Formula | C6H15ClN2O2 |
Canonical SMILES | [2H]C([2H])([C@@H](C(=O)O)N)C([2H])([2H])C([2H])([2H])C([2H])([2H])N.Cl |
InChI | InChI=1S/C21H13NO3/c23-19-15-8-4-5-9-16(15)20(24)18-12-14(10-11-17(18)19)22-21(25)13-6-2-1-3-7-13/h1-12H,(H,22,25) |
InChIKey | SIGATAYQAZTAOH-UHFFFAOYSA-N |
Purity | >98% |
Solubility | Soluble in DMSO. |
Appearance | Solid |
Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |